IMPORTANT info left out — Recent clinical trials showed no major difference between this drug and a placebo, and the stock price for the company tanked. So, for now, the research continues.
Buried at the end:
"Another study failed to show improvements in hearing compared to the placebo group, but the company attributes that result to flaws in the design of the trial."